Skip to main content
. Author manuscript; available in PMC: 2010 Jan 25.
Published in final edited form as: J Urol. 2008 Apr 23;179(6):2416–2421. doi: 10.1016/j.juro.2008.01.092

Table 3.

Risk estimate for BPDE-induced 3p deletions with subjects grouped according to the quartile distribution in the controls

No. (%)
Adjusted OR (95% CI)* p for trend
Cases Controls
3p25.2 deletion
 1st quartile 16 (11.5) 18 (17.5) Reference
 2nd quartile 28 (20.1) 31 (30.1) 1.15 (0.47–2.78)
 3rd quartile 25 (25.2) 27 (26.2) 1.63 (0.68–3.90)
 4th quartile 60 (43.2) 27 (26.2) 2.80 (1.20–6.57) 0.004
3p21.3 deletion
 1st quartile 18 (12.2) 24 (22.2) Reference
 2nd quartile 26 (17.6) 26 (24.1) 1.42 (0.61–3.30)
 3rd quartile 43 (29.0) 27 (25.0) 2.48 (1.11–5.57)
 4th quartile 61 (41.2) 31 (28.7) 3.04 (1.39–6.64) 0.002
3p14.2 deletion
 1st quartile 7 (5.2) 24 (22.6) Reference
 2nd quartile 36 (26.7) 24 (22.6) 5.04 (1.82–13.9)
 3rd quartile 40 (29.6) 28 (26.4) 5.09 (1.91–13.6)
 4th quartile 52 (38.5) 30 (28.4) 5.95 (2.21–16.0) 0.003
3p12.2 deletion
 1st quartile 21 (15.3) 20 (18.6) Reference
 2nd quartile 20 (14.6) 30 (28.0) 0.64 (0.27–1.49)
 3rd quartile 44 (32.1) 30 (28.0) 1.31 (0.59–2.90)
 4th quartile 52 (38.0) 27 (25.2) 1.78 (0.81–3.89) 0.028
*

Odds ratio (OR) adjusted for age (as a continuous variable), gender, ethnicity, and smoking status; data are means and 95% confidence intervals (CI)

Not all patients and controls had completed analysis for deletions at each locus